title: Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
authors.forename: Tien-Yi
authors.initials: TY
authors.lastname: Tzung
authors.forename: Ching-Yin
authors.initials: CY
authors.lastname: Chen
authors.forename: Chia-Yi
authors.initials: CY
authors.lastname: Yang
authors.forename: Pei-Yu
authors.initials: PY
authors.lastname: Lo
authors.forename: Ya-Hui
authors.initials: YH
authors.lastname: Chen
mesh_terms: D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D012720:Severity of Illness Index; D016037:Single-Blind Method
chemical_list: D003879:Dermatologic Agents; D005938:Glucocorticoids; C055085:calcipotriene; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D002117:Calcitriol